Anti-Obesity, Lipid-Lowering, and Anti-Hyperglycemic Effects of CB-02 in High-Fat-Diet-Induced Obese Mice
Open Access
- 10 September 2025
- Vol. 30 (18) , 3678
Abstract
Obesity, along with dyslipidemia and hyperglycemia, is a metabolic disorder growing in prevalence that is linked to chronic diseases such as atherosclerosis, hypertension, and type 2 diabetes. This study evaluated the anti-obesity, lipid-lowering, and anti-hyperglycemic effects of CB-02 capsules containing dry extracts of Phyllanthus emblica L., Dendrobium catenatum Lindl., and Gynostemma pentaphyllum in HFD-induced obese Swiss albino mice. After 12 weeks of HFD induction, mice were treated orally with CB-02 (576 or 1152 mg/kg/day) for 8 weeks. CB-02 significantly reduced BW gain, AC, the Lee obesity index, and the relative weights of visceral fat and major organs. It also improved lipid profiles by decreasing TC, TG, LDL-C, and non-HDL-C, while increasing HDL-C. These effects were comparable to orlistat (60 mg/kg/day). Furthermore, CB-02 lowered fasting glucose and improved insulin sensitivity, as indicated by an increased QUICKI and HOMA-β and reduced HOMA-IR. Histopathological evaluation showed that CB-02 reduced hepatic steatosis and inflammatory cell infiltration and also attenuated β-cell morphological alterations and pancreatic histopathological damage. These results suggest that CB-02 may be a promising therapeutic candidate for managing obesity and its comorbidities, including dyslipidemia, hyperglycemia, and hepatic steatosis, contributing to the prevention of type 2 diabetes and cardiovascular diseases in obese individuals.Keywords
All Related Versions
This publication has 59 references indexed in Scilit:
- Functional effects and mechanisms of Phyllanthus emblica fruit and gallic acid on metabolic diseases: Experimental evidence and clinical perspectivesFood Bioscience, 2024
- Dendrobium officinale regulate lipid metabolism in diabetic mouse liver via PPAR-RXR signaling pathway: Evidence from an integrated multi-omics analysisBiomedicine & Pharmacotherapy, 2024
- High‐fat diet induced obesity promotes inflammation, oxidative stress, and hepatotoxicity in female FVB/N miceBioFactors, 2024
- Polysaccharides from Dendrobium officinale improve obesity‐induced insulin resistance through the gut microbiota and the SOCS3‐mediated insulin receptor substrate‐1 signaling pathwayJournal of the Science of Food and Agriculture, 2024
- Phyllanthus emblica L. extract alleviates leptin resistance and lipid accumulation by inhibiting methylglyoxal productionFood Bioscience, 2023
- Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?Current Obesity Reports, 2021
- A Review of the Efficacy, Safety, and Clinical Implications of Naturally Derived Dietary Supplements for DyslipidemiaAmerican Journal of Cardiovascular Drugs, 2016
- FDA-Approved Anti-Obesity Drugs in the United StatesThe American Journal of Medicine, 2016
- Hypoglycemic effect of Gynostemma pentaphyllum saponins by enhancing the Nrf2 signaling pathway in STZ-inducing diabetic ratsArchives of Pharmacal Research, 2014
- Overview of Animal Models of ObesityCurrent Protocols in Pharmacology, 2012